{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:18:57Z","timestamp":1787501937626,"version":"build-2736575974"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi & Co. Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Understand how mutations upstream of pvdS and fecI in Pseudomonas aeruginosa PAO1 lead to reduced susceptibility to cefiderocol, a siderophore cephalosporin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Whole-genome sequencing, gene complementation and inactivation, mRNA expression, siderophore quantification and supplementation were carried out with mutants that showed reduced susceptibility to cefiderocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Whole-genome sequencing, combined with gene complementation studies, with isolated mutants that showed 4-fold reduced susceptibility to cefiderocol identified mutations within the Fur-box of promoter regions upstream of pvdS and fecI. The pvdS promoter mutation led to increased pvdS transcription, resulting in increased pyoverdine production, as well as reduced transcription of other iron transport-related genes, including piuA an iron transporter responsible for cefiderocol uptake. The down-regulation of piuA, rather than competition for iron between pyoverdine and cefiderocol, was responsible for the decreased cefiderocol susceptibility. The fecI mutant demonstrated increased transcription of fecI and fecA, and the expression level of piuA in the fecI mutant was not related to reduced cefiderocol susceptibility, indicating a different mechanism for the reduced cefiderocol susceptibility in this mutant. Sequence analyses of over 35\u200a000 clinical P. aeruginosa isolates did not identify isolates with the pvdS mutation, and only one isolate with the fecI mutation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These data highlight different mechanisms by which P. aeruginosa attempts to evade the action of cefiderocol by exploiting the complexities of iron haemostasis in bacteria. The absence of such mutants in the clinic suggests that such mutations may be detrimental for P. aeruginosa to survive in the clinical environment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag004","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:45:35Z","timestamp":1767789935000},"source":"Crossref","is-referenced-by-count":2,"title":["Understanding mechanisms of reduced cefiderocol susceptibility in\n                    <i>pvdS<\/i>\n                    and\n                    <i>fecI<\/i>\n                    mutants of\n                    <i>Pseudomonas aeruginosa<\/i>"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7860-8863","authenticated-orcid":false,"given":"Yoshinori","family":"Yamano","sequence":"first","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Takemura","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Longshaw","sequence":"additional","affiliation":[{"name":"Shionogi B.V. Scientific Affairs, , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boudewijn L M","family":"DeJonge","sequence":"additional","affiliation":[{"name":"Shionogi Inc. US Medical Affairs, , Florham Park, NJ ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Ishii","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rio","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Kuroiwa","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshino","family":"Ishioka","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Adachi","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Rokushima","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Maki","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Sato","sequence":"additional","affiliation":[{"name":"Shionogi & Co., Ltd. Drug Discovery Research Division, , Toyonaka, Osaka 561-0825 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"Suppl 7","key":"2026013007010843200_dkag004-B1","doi-asserted-by":"publisher","first-page":"S544","DOI":"10.1093\/cid\/ciz827","article-title":"In vitro activity of cefiderocol against a broad range of clinically important Gram-negative bacteria","volume":"69","author":"Yamano","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"2026013007010843200_dkag004-B2","doi-asserted-by":"publisher","first-page":"S538","DOI":"10.1093\/cid\/ciz826","article-title":"Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin","volume":"69","author":"Sato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026013007010843200_dkag004-B3","doi-asserted-by":"publisher","first-page":"e0199021","DOI":"10.1128\/AAC.01990-21","article-title":"In vitro susceptibility of Gram-negative pathogens to cefiderocol in five consecutive annual multinational SIDERO-WT surveillance studies, 2014 to 2019","volume":"66","author":"Karlowsky","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B4","doi-asserted-by":"publisher","first-page":"e01474-24","DOI":"10.1128\/spectrum.01474-24","article-title":"In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including \u03b2-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals","volume":"12","author":"Kimbrough","year":"2024","journal-title":"Microbiol Spectr"},{"key":"2026013007010843200_dkag004-B5","doi-asserted-by":"publisher","first-page":"e01454-17","DOI":"10.1128\/AAC.01454-17","article-title":"In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria","volume":"62","author":"Ito","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B6","doi-asserted-by":"publisher","first-page":"e00097-18","DOI":"10.1128\/AAC.00097-18","article-title":"TonB-dependent receptor repertoire of Pseudomonas aeruginosa for uptake of siderophore-drug conjugates","volume":"62","author":"Luscher","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B7","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1093\/jac\/dkae326","article-title":"Impact of transferable \u03b2-lactamases and intrinsic AmpC amino acid substitutions on the activity of cefiderocol against wild-type and iron uptake-deficient mutants of Pseudomonas aeruginosa","volume":"79","author":"Gonz\u00e1lez-Pinto","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026013007010843200_dkag004-B8","doi-asserted-by":"publisher","first-page":"e01192-23","DOI":"10.1128\/aac.01192-23","article-title":"Emergence of cefiderocol resistance during ceftazidime\/avibactam treatment caused by a large genomic deletion, including ampD and piuCD genes, in Pseudomonas aeruginosa","volume":"68","author":"Gomis-Font","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B9","doi-asserted-by":"publisher","first-page":"ofab311","DOI":"10.1093\/ofid\/ofab311","article-title":"Cefiderocol activity against clinical Pseudomonas aeruginosa isolates exhibiting ceftolozane-tazobactam resistance","volume":"8","author":"Simner","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2026013007010843200_dkag004-B10","doi-asserted-by":"publisher","first-page":"e01009-23","DOI":"10.1128\/aac.01009-23","article-title":"The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy","volume":"68","author":"Teran","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41564-024-01601-4","article-title":"Siderophores promote cooperative interspecies and intraspecies cross-protection against antibiotics in vitro","volume":"9","author":"Galdino","year":"2024","journal-title":"Nature Microbiol"},{"key":"2026013007010843200_dkag004-B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10534-008-9193-0","article-title":"Iron uptake regulation in Pseudomonas aeruginosa","volume":"22","author":"Cornelis","year":"2009","journal-title":"Biometals"},{"key":"2026013007010843200_dkag004-B13","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.bbagrm.2018.04.008","article-title":"Extracytoplasmic function sigma factors in Pseudomonas aeruginosa","volume":"1862","author":"Chevalier","year":"2019","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"2026013007010843200_dkag004-B14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10534-010-9361-x","article-title":"Siderophore uptake in bacteria and the battle for iron with the host; a bird\u2019s eye view","volume":"23","author":"Chu","year":"2010","journal-title":"Biometals"},{"key":"2026013007010843200_dkag004-B15","doi-asserted-by":"publisher","first-page":"14339","DOI":"10.1073\/pnas.2036282100","article-title":"Comprehensive transposon mutant library of Pseudomonas aeruginosa","volume":"100","author":"Jacobs","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026013007010843200_dkag004-B16","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1128\/AAC.00831-15","article-title":"Pharmacodynamic profiling of a siderophore-conjugated monocarbam in Pseudomonas aeruginosa: assessing the risk for resistance and attenuated efficacy","volume":"59","author":"Kim","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1021\/ml200012f","article-title":"Preparation, Gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols","volume":"2","author":"Flanagan","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"2026013007010843200_dkag004-B18","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1128\/AAC.01525-09","article-title":"In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant Gram-negative bacilli","volume":"54","author":"Page","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B19","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/biology11121711","article-title":"A review of Pseudomonas aeruginosa metallophores: pyoverdine, pyochelin and pseudopaline","volume":"11","author":"Ghssein","year":"2022","journal-title":"Biology (Basel)"},{"key":"2026013007010843200_dkag004-B20","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing\u2014Thirty-Fourth Edition: M100","author":"Clinical and Laboratory Standards Institute","year":"2024"},{"key":"2026013007010843200_dkag004-B21","doi-asserted-by":"publisher","first-page":"e00471-25","DOI":"10.1128\/jcm.00471-25","article-title":"The impact of commercially available media on cefiderocol susceptibility testing by broth microdilution method","volume":"63","author":"DeJonge","year":"2025","journal-title":"J Clin Microbiol"},{"key":"2026013007010843200_dkag004-B22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1074\/mcp.RA119.001829","article-title":"Phenotypic adaption of Pseudomonas aeruginosa by hacking siderophores produced by other microorganisms","volume":"19","author":"Perraud","year":"2020","journal-title":"Mol Cell Proteomics"},{"key":"2026013007010843200_dkag004-B23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF02456609","article-title":"A positive regulatory gene, pvdS, for expression of pyoverdin biosynthetic genes in Pseudomonas aeruginosa PAO","volume":"248","author":"Miyazaki","year":"1995","journal-title":"Mol Gen Genet"},{"key":"2026013007010843200_dkag004-B24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1128\/JB.182.6.1481-1491.2000","article-title":"Functional analysis of PvdS, an iron starvation sigma factor of Pseudomonas aeruginosa","volume":"182","author":"Leoni","year":"2000","journal-title":"J Bacteriol"},{"key":"2026013007010843200_dkag004-B25","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1128\/JB.01376-13","article-title":"Pvdp is a tyrosinase that drives maturation of the pyoverdine chromophore in Pseudomonas aeruginosa","volume":"196","author":"Nadal-Jimenez","year":"2014","journal-title":"J Bacteriol"},{"key":"2026013007010843200_dkag004-B26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.15698\/mic2018.10.649","article-title":"The biosynthesis of pyoverdines","volume":"5","author":"Ringel","year":"2018","journal-title":"Microbial Cell"},{"key":"2026013007010843200_dkag004-B27","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.3390\/ijms24109078","article-title":"Revisiting fur regulon leads to a comprehensive understanding of iron and fur regulation","volume":"24","author":"Hou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026013007010843200_dkag004-B28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1369-5274(03)00022-5","article-title":"Regulation of the FecI-type ECF sigma factor by transmembrane signalling","volume":"6","author":"Braun","year":"2003","journal-title":"Curr Opin Microbiol"},{"key":"2026013007010843200_dkag004-B29","doi-asserted-by":"publisher","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B30","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1128\/AAC.01345-12","article-title":"Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam","volume":"56","author":"McPherson","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B31","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-019-11508-y","article-title":"The complex of ferric-enterobactin with its transporter from Pseudomonas aeruginosa suggests a two-site model","volume":"10","author":"Moyni\u00e9","year":"2019","journal-title":"Nat Commun"},{"key":"2026013007010843200_dkag004-B32","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1093\/jac\/dkac347","article-title":"The acquisition of transferable extrachromosomal fec operon is associated with a cefiderocol MIC increase in Enterobacterales","volume":"77","author":"Kaan","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2026013007010843200_dkag004-B33","doi-asserted-by":"publisher","first-page":"e01942-24","DOI":"10.1128\/aac.01942-24","article-title":"Mutant prevention concentrations and phenotypic and genomic profiling of first-step resistance mechanisms to classical and novel \u03b2-lactams in Pseudomonas aeruginosa","volume":"69","author":"Sastre-Femenia","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"2026013007010843200_dkag004-B34","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1093\/jac\/dkad172","article-title":"In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa","volume":"78","author":"Gomis-Font","year":"2023","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/2\/dkag004\/66640141\/dkag004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/2\/dkag004\/66640141\/dkag004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:01:12Z","timestamp":1769774472000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag004\/8445351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,19]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag004","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,19]]},"article-number":"dkag004"}}